In today’s dynamic healthcare landscape, the ability to generate compelling, credible, and timely evidence has never been more critical. Whether demonstrating the value of an innovative therapy, shaping clinical practice, or addressing unanswered questions in the minds of key stakeholders, effective evidence generation planning is what transforms data into meaningful, real-world impact.
Evidence generation isn’t a checklist, it’s a strategic journey: from insight to action. Spending time upfront to define a robust strategic plan helps ensure evidence generation activities are purposeful, coordinated, and aligned to the broader brand or disease strategy. When done well, this process ensures that every piece of evidence contributes to a clear narrative—one that informs, influences, and inspires change throughout the product lifecycle.
1. Building a Foundation for Smarter Decisions
Every impactful evidence generation strategy begins with a deep understanding of the landscape. Effective strategies are built on robust insights and a nuanced appreciation of stakeholder beliefs, motivations, and decision drivers.
At AXON, we often see teams rush to design studies or generate data without first investing the time to listen, analyze, and anticipate. Yet it’s this early work that makes the difference. A comprehensive landscape scan—encompassing stakeholder perspectives, competitor activity, evolving policy, and clinical practice trends—reveals not just where evidence gaps exist, but why they matter.
These insights form the foundation for smarter, more targeted strategies. They help challenge internal assumptions, validate or reprioritize evidence needs, and identify real-world data sources that can accelerate delivery. When combined, these insights ensure that every piece of evidence resonates both scientifically and emotionally, strengthening relevance and credibility in the eyes of key decision-makers.
2. Co-Creating Strategies That Drive Action
Evidence generation planning is as much about alignment and collaboration as it is about scientific research program design. The most effective strategies emerge when cross-functional teams—from clinical development and medical affairs to health economics and outcomes research, real world evidence, and market access—come together to co-create a shared vision.
Bringing these voices together in one process isn’t always easy; competing priorities, limited time, and differing regional perspectives can make consensus elusive. However, when teams take the time to co-create, they gain something more valuable than a plan: they build collective ownership.
Effective cross-functional engagement enables teams to:
- Prioritize the most critical evidence needs
- Define clear research questions and appropriate methodologies
- Align on the purpose, timing, and use of evidence outputs
This collaborative approach ensures that evidence generation is not an isolated activity but a coordinated effort: one that drives consistency, efficiency, and shared accountability across global, regional, and affiliate teams.
3. Ensuring Evidence Reaches the Right Audience
Even the most rigorous evidence has little impact if it doesn’t reach the people it’s meant to influence. That’s why strategic planning must go beyond generation and must encompass dissemination.
An effective evidence generation plan clearly articulates who needs to see the evidence, why it matters to them, and how it should be communicated. Whether through traditional peer-reviewed publications, congress presentations, or digital and social channels, dissemination must be deliberate.
A strong omnichannel dissemination strategy ensures that insights travel the full distance, from publication to practice. It helps evidence to stand out amid information overload, driving awareness, adoption, and ultimately behavior change. When paired with measurement frameworks such as impact tracking, sentiment analysis, or policy monitoring, it ensures that the impact of evidence is not only achieved but captured.